| # | Drug | Count |
|---|---|---|
| 0 | DUPILUMAB | 398 |
| 1 | SECUKINUMAB | 351 |
| 2 | PREDNISONE | 273 |
| 3 | ASPIRIN | 244 |
| 4 | ERGOCALCIFEROL | 236 |
| 5 | ASPIRIN 81 MG | 234 |
| 6 | ASPIRIN 325 MG | 233 |
| 7 | METHOTREXATE SODIUM | 195 |
| 8 | LENALIDOMIDE | 182 |
| 9 | METHOTREXATE | 180 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AVOBENZONE, HOMOSALATE, OCTOCRYLENE, OCTISALATE | 4 | 0.0268 |
| 1 | AVOBENZONE, HOMOSALATE, OCTISALAT, OCTOCRYLENE | 3 | 0.0213 |
| 2 | FLUOCINOLONE ACETONIDE, HYDROQUINONE, AND TRETINOIN | 11 | 0.0201 |
| 3 | 2%MENTHOL | 20 | 0.0193 |
| 4 | COUGH SUPPRESSANT | 20 | 0.0191 |
| 5 | SETMELANOTIDE | 5 | 0.0175 |
| 6 | HYDROQUINONE | 6 | 0.0101 |
| 7 | CEFADROXIL | 20 | 0.0098 |
| 8 | MINOCYCLINE | 110 | 0.0094 |
| 9 | PSYLLIUM HUSK | 11 | 0.0081 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 634 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 512 |
| 2 | Interleukin-4 Receptor alpha Antagonist [EPC] | 398 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 251 |
| 4 | Benzodiazepine [EPC] | 246 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 226 |
| 6 | Proton Pump Inhibitor [EPC] | 224 |
| 7 | Kinase Inhibitor [EPC] | 211 |
| 8 | Thalidomide Analog [EPC] | 199 |
| 9 | Mood Stabilizer [EPC] | 198 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Melanocortin 4 Receptor Agonist [EPC] | 5 | 0.0175 |
| 1 | Melanin Synthesis Inhibitor [EPC] | 17 | 0.0149 |
| 2 | Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] | 3 | 0.0050 |
| 3 | Paramagnetic Contrast Agent [EPC] | 17 | 0.0037 |
| 4 | Diagnostic Dye [EPC] | 2 | 0.0031 |
| 5 | Aryl Hydrocarbon Receptor Agonist [EPC] | 6 | 0.0030 |
| 6 | Cortisol Synthesis Inhibitor [EPC] | 2 | 0.0026 |
| 7 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 1 | 0.0026 |
| 8 | CD52-directed Cytolytic Antibody [EPC] | 45 | 0.0023 |
| 9 | Sclerosing Agent [EPC] | 1 | 0.0022 |